Abstract

Extracts from saffron are used for treatment of cancer and depression. Because of known quality problems HPLC methods on RP18 2.5µm and monolitic RP18 material were developed for quality control including the quantification of crocins 1 to 5, crocetin, picrocrocin and the degradation products cis-crocins. A GC-MS method allowed detection and quantification of the volatile compounds from saffron pentane extract. Both systems together allowed comprehensive characterization of saffron herbal material and extracts for clinical/preclinical trials. Based on a wide analytical survey of saffron from the global market a specification for high-quality saffron of >20% crocins, >6% picrocrocin and not less than 0.3% of volatiles, calculated as sum of safranal, isophorone and ketoisophorone, was developed.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.